Macoin, Julie, Rami Lissilaa, Pavankumar Sancheti, Venkateshwar Reddy, Jonathan Back, and Gerhard Wolff. “Targeting OX40 With GBR 830, An OX40 Antagonist, Inhibits T Cell-Mediated Pathological Responses”. SKIN The Journal of Cutaneous Medicine 2 (December 17, 2018): S62. Accessed September 20, 2024. https://dermsquared.com/skin/article/view/458.